http://www.camargoblog.com Drug Development Comments - Focused on 505(b)(2) Mon, 30 Apr 2012 13:05:11 +0000 en hourly 1 http://wordpress.org/?v=3.2.1 http://www.camargoblog.com/index.php/2012/04/30/viropharma-loses-exclusivity-appeal/ http://www.camargoblog.com/index.php/2012/04/30/viropharma-loses-exclusivity-appeal/#comments Mon, 30 Apr 2012 13:05:11 +0000 admin http://www.camargoblog.com/?p=1397 http://www.camargoblog.com/index.php/2012/04/30/viropharma-loses-exclusivity-appeal/feed/ 0 http://www.camargoblog.com/index.php/2012/04/20/supreme-court-upholds-counterclaim-provision-for-overbroad-orange-book-use-codes-entries-in-anda-patent-infringement-suits/ http://www.camargoblog.com/index.php/2012/04/20/supreme-court-upholds-counterclaim-provision-for-overbroad-orange-book-use-codes-entries-in-anda-patent-infringement-suits/#comments Fri, 20 Apr 2012 20:31:43 +0000 admin http://www.camargoblog.com/?p=1385 http://www.camargoblog.com/index.php/2012/04/20/supreme-court-upholds-counterclaim-provision-for-overbroad-orange-book-use-codes-entries-in-anda-patent-infringement-suits/feed/ 0 http://www.camargoblog.com/index.php/2012/04/19/viropharma-denied-request-for-3-year-exclusivity/ http://www.camargoblog.com/index.php/2012/04/19/viropharma-denied-request-for-3-year-exclusivity/#comments Thu, 19 Apr 2012 23:51:10 +0000 admin http://www.camargoblog.com/?p=1367 http://www.camargoblog.com/index.php/2012/04/19/viropharma-denied-request-for-3-year-exclusivity/feed/ 0 http://www.camargoblog.com/index.php/2012/04/15/drug-development-planned-like-the-titanic/ http://www.camargoblog.com/index.php/2012/04/15/drug-development-planned-like-the-titanic/#comments Sun, 15 Apr 2012 14:00:04 +0000 admin http://www.camargoblog.com/?p=1343 http://www.camargoblog.com/index.php/2012/04/15/drug-development-planned-like-the-titanic/feed/ 0 http://www.camargoblog.com/index.php/2012/04/12/nih-head-urges-repositioningrepurposing/ http://www.camargoblog.com/index.php/2012/04/12/nih-head-urges-repositioningrepurposing/#comments Thu, 12 Apr 2012 20:32:43 +0000 admin http://www.camargoblog.com/?p=1359 http://www.camargoblog.com/index.php/2012/04/12/nih-head-urges-repositioningrepurposing/feed/ 0 http://www.camargoblog.com/index.php/2012/04/02/generic-vs-505b2-failure-to-warn-liability/ http://www.camargoblog.com/index.php/2012/04/02/generic-vs-505b2-failure-to-warn-liability/#comments Mon, 02 Apr 2012 13:41:04 +0000 admin http://www.camargoblog.com/?p=1341 http://www.camargoblog.com/index.php/2012/04/02/generic-vs-505b2-failure-to-warn-liability/feed/ 0 http://www.camargoblog.com/index.php/2012/01/09/2011-505b2-approvals-now-exceed-505b1-nda-approvals/ http://www.camargoblog.com/index.php/2012/01/09/2011-505b2-approvals-now-exceed-505b1-nda-approvals/#comments Mon, 09 Jan 2012 16:14:11 +0000 admin http://www.camargoblog.com/?p=1335 http://www.camargoblog.com/index.php/2012/01/09/2011-505b2-approvals-now-exceed-505b1-nda-approvals/feed/ 0 http://www.camargoblog.com/index.php/2011/12/21/what-is-an-approved-desi-product/ http://www.camargoblog.com/index.php/2011/12/21/what-is-an-approved-desi-product/#comments Wed, 21 Dec 2011 15:25:39 +0000 admin http://www.camargoblog.com/?p=1317 http://www.camargoblog.com/index.php/2011/12/21/what-is-an-approved-desi-product/feed/ 0 http://www.camargoblog.com/index.php/2011/10/04/stability-changes-coming-to-andas/ http://www.camargoblog.com/index.php/2011/10/04/stability-changes-coming-to-andas/#comments Tue, 04 Oct 2011 19:03:13 +0000 admin http://www.camargoblog.com/?p=1310 http://www.camargoblog.com/index.php/2011/10/04/stability-changes-coming-to-andas/feed/ 0 http://www.camargoblog.com/index.php/2011/10/03/dont-launch-unapproved-products-after-9192011/ http://www.camargoblog.com/index.php/2011/10/03/dont-launch-unapproved-products-after-9192011/#comments Mon, 03 Oct 2011 20:48:33 +0000 admin http://www.camargoblog.com/?p=1307 http://www.camargoblog.com/index.php/2011/10/03/dont-launch-unapproved-products-after-9192011/feed/ 0